Stardom Pharmaceuticals Private Limited
About Stardom Pharmaceuticals Private Limited
Data last updated:
Stardom Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2010PTC211417. Its GSTIN is 24AAPCS1012C1ZX (Gujarat).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Madhu Ranjit Sharma and Nikhil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at M – 54 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹89.58 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net profit of ₹1.26 Lakh (net margin 1.4%) and EBITDA of ₹2.06 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Stardom Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressM – 54 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Stardom Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Stardom Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stardom Pharmaceuticals Private Limited, buy the company report.
Financials of Stardom Pharmaceuticals Private Limited
FY 2024 filings availableStardom Pharmaceuticals Private Limited reported revenue of ₹89.58 Lakh (down 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 43% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stardom Pharmaceuticals Private Limited, buy the company report.
Board of directors of Stardom Pharmaceuticals Private Limited
Stardom Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhu Ranjit Sharma | Director | 03 Dec 2021 | 4 Years 10 Months | Current |
| Rajeev Ranjan Also directs: Avison Pharmaceuticals Private Limited | Additional Director | 16 May 2025 | 1 Years 5 Months | Current |
| Nikhil Kumar | Director | 19 Jun 2024 | 2 Years 4 Months | Current |
| Kaushal Kumar Mishra | Additional Director | 28 Jun 2024 | 2 Years 4 Months | Current |
| Alok Ranjan | Additional Director | 27 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Stardom Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medvision Innovation Private Limited | ₹89.89 Lakh (FY 2025) | 1201.0% | Delhi, India | |||
| Akola Pharmaceuticals Private Limited | ₹89.88 Lakh (FY 2025) | 397.0% | Akola, Maharashtra, India | |||
| Cygnus Health Care Specialities Private Limited | ₹89.63 Lakh (FY 2024) | -62.0% | Thane, Maharashtra, India | |||
| Stardom Pharmaceuticals Private Limitedthis company | ₹89.58 Lakh (FY 2025) | ₹1.26 Lakh | 1.4% | -43.0% | New Delhi, Delhi, India | |
| Aph Pharmaceuticals Private Limited | ₹89.53 Lakh (FY 2022) | -16.0% | Noida, Uttar Pradesh, India | |||
| Stride Health Care Private Limited | ₹89.23 Lakh (FY 2024) | -13.0% | Chandigarh, India |
To see the full peer comparison of Stardom Pharmaceuticals Private Limited, buy the company report.
Auditor
Stardom Pharmaceuticals Private Limited is audited by MEHUL G SHAH & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEHUL G SHAH & CO | FY 2023 | 118829W |
Shareholding
The shareholding of Stardom Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Stardom Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Stardom Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stardom Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stardom Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPCS1012C1ZX | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Stardom Pharmaceuticals Private Limited, buy the company report.
Recent activity
Stardom Pharmaceuticals Private Limited has 11 board changes on record since 2015: 5 appointments and 6 cessations. The latest: Rajeev Ranjan was appointed as Additional Director on 16 May 2025.
2 earlier events are in the company report.
Frequently asked questions
Stardom Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 December 2010 (16+ years old) and is registered under CIN U24232DL2010PTC211417.
Stardom Pharmaceuticals has 5 current directors:
- Madhu Ranjit Sharma - Director
- Rajeev Ranjan - Additional Director
- Nikhil Kumar - Director
- Kaushal Kumar Mishra - Additional Director
- Alok Ranjan - Additional Director
The latest financial statements of Stardom Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Stardom Pharmaceuticals is 24AAPCS1012C1ZX, registered in Gujarat.
The CIN (Corporate Identification Number) of Stardom Pharmaceuticals is U24232DL2010PTC211417. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stardom Pharmaceuticals was incorporated on 14 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Stardom Pharmaceuticals by revenue are Medvision Innovation Private Limited, Akola Pharmaceuticals Private Limited, Cygnus Health Care Specialities Private Limited, Aph Pharmaceuticals Private Limited, Stride Health Care Private Limited, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment, Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajeev Ranjan was appointed as Additional Director on 16 May 2025. Alok Ranjan was appointed as Additional Director on 27 Mar 2025. Kaushal Kumar Mishra ceased to be Additional Director on 29 Sep 2024. Stardom Pharmaceuticals has 11 board changes on record in total.
The registered office of Stardom Pharmaceuticals is at M – 54 Ground Floor Kalkaji, New Delhi, Delhi, India – 110019.
Stardom Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Stardom Pharmaceuticals is compliant as of 29 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
